The following discussion should be read in conjunction with the unaudited
condensed consolidated financial statements and notes thereto included herein
and with our audited consolidated financial statements and notes thereto for the
fiscal year ended December 31, 2021, which are contained in our fiscal 2021
Annual Report on Form 10-K, which was filed with the U.S. Securities and
Exchange Commission on February 25, 2022 (our "2021 Annual Report").

Forward-Looking Statements



This Quarterly Report on Form 10-Q contains certain "forward-looking" statements
(as such term is defined in the Private Securities Litigation Reform Act of
1995, and the rules promulgated pursuant to the Securities Act of 1933, as
amended, and the Securities Exchange Act of 1934, as amended) that are based on
the beliefs of our management, as well as assumptions made by and information
currently available to our management. Such forward-looking statements are
subject to the safe harbor created by the Private Securities Litigation Reform
Act of 1995. When used in this document, the words "intend," "anticipate,"
"believe," "estimate," "expect" and similar expressions, as they relate to us or
our management, identify such forward-looking statements. Such statements
reflect the current views of us or our management with respect to future events
and are subject to certain risks, uncertainties and assumptions. Should one or
more of these risks or uncertainties materialize, or should underlying
assumptions prove incorrect, our actual results, performance, or achievements
could differ materially from those expressed in, or implied by, any such
forward-looking statements. Factors that could cause or contribute to such
material differences include the global economic downturn, the COVID-19 pandemic
(including factors relating to measures implemented by governmental authorities
or by us to promote the safety of our employees, vendors and clients; other
direct and indirect impacts on our business and the businesses of our clients,
vendors and other partners; impacts which may, among other things, adversely
affect our clients' ability to utilize our services at the levels they have
previously; disruptions of access to our facilities or those of our clients or
third parties; and increased and potentially significant economic uncertainty
and volatility, including credit and collectability risks and potential
disruptions of capital and credit markets), the possibility that the demand for
our services may decline as a result of changes in general and industry specific
economic conditions, the timing of engagements for our services, the effects of
competitive services and pricing, the absence of backlog related to our
business, our ability to attract and retain key employees, the effect of tort
reform and government regulation on our business and liabilities resulting from
claims made against us. Additional risks and uncertainties are discussed in this
Quarterly Report under the heading "Risk Factors" and elsewhere in this report.
The inclusion of such forward-looking information should not be regarded as a
representation by the us or any other person that the future events, plans, or
expectations we contemplated will be achieved. Due to such uncertainties and
risks, you are warned not to place undue reliance on such forward-looking
statements, which speak only as of the date hereof. We do not intend to release
publicly any updates or revisions to any such forward-looking statements.

Business Overview

Exponent, Inc., is an engineering and scientific consulting firm that provides
solutions to complex problems. Our multidisciplinary team of scientists,
engineers and business consultants brings together more than 90 different
technical disciplines to solve complicated issues facing industry and business
today. Our services include analysis of product development, product recall,
regulatory compliance, and the discovery of potential problems related to
products, people, property and impending litigation.

CRITICAL ACCOUNTING ESTIMATES

There have been no significant changes in our critical accounting estimates during the nine months ended September 30, 2022, as compared to the critical accounting estimates disclosed in Management's Discussion and Analysis of Financial Condition and Results of Operations included in our 2021 Annual Report.


                                     - 20 -
--------------------------------------------------------------------------------

RESULTS OF CONSOLIDATED OPERATIONS

Executive Summary



Revenues for the third quarter of 2022 increased 9% to $127,179,000 as compared
to $116,405,000 during the same period last year. Revenues before reimbursements
for the third quarter of 2022 increased 6% to $115,143,000 as compared to
$108,467,000 during the same period last year.

During the third quarter of 2022, our proactive engagements within consumer
products and transportation remained a key driver of our performance as demand
for our work related to virtual reality, wearable technologies, and energy
storage increased. At the same time, our reactive business continued to benefit
from an increase in litigation activity and a diversified portfolio of product
safety- and recall-related work, particularly in the life sciences space.

Net income decreased 1% to $24,442,000 during the third quarter of 2022 as
compared to $24,574,000 during the same period last year. Diluted earnings per
share increased to $0.47 per share as compared to $0.46 in the same period last
year.

We remain focused on selectively adding top talent and developing the skills
necessary to expand our market position and providing clients with in-depth
scientific research and analysis to determine what happened and how to prevent
failures or exposures in the future. We also remain focused on capitalizing on
emerging growth areas, managing other operating expenses, generating cash from
operations, maintaining a strong balance sheet and undertaking activities such
as share repurchases and dividends to enhance shareholder value.

Overview of the Three Months Ended September 30, 2022



During the third quarter of 2022, billable hours increased 5% to 365,000 as
compared to 348,000 during the same period last year. Our utilization decreased
to 73% during the third quarter of 2022 as compared to 76% during the same
period last year. Technical full-time equivalent employees increased 8% to 958
during the third quarter of 2022 as compared to 883 during the same period last
year. We continue to selectively hire key talent to expand our capabilities.

Three Months Ended September 30, 2022 compared to Three Months Ended October 1,
2021

Revenues

                                            Three Months Ended
                                      September 30,       October 1,       Percent
(in thousands, except percentages)        2022               2021          

Change

Engineering and Other Scientific $ 107,403 $ 97,100

   10.6 %
Percentage of total revenues                    84.5 %           83.4 %
Environmental and Health                      19,776           19,305           2.4 %
Percentage of total revenues                    15.5 %           16.6 %
Total revenues                       $       127,179     $    116,405           9.3 %



The increase in revenues for our Engineering and Other Scientific segment was
due to an increase in billable hours and an increase in billing rates. During
the third quarter of 2022, billable hours for this segment increased by 6% to
291,000 as compared to 275,000 during the same period last year. Utilization for
this segment decreased to 76% during the third quarter of 2022 as compared to
78% during the same period last year. The increase in billable hours was driven
by an increase in demand for our services across the consumer products,
utilities, and automotive sectors. Utilization during the second quarter of 2021
was historically strong. Technical full-time equivalent employees in this
segment increased 10% to 742 during the third quarter of 2022 as compared to 675
for the same period last year due to our recruiting and retention efforts.

The increase in revenues for our Environmental and Health segment was due to an
increase in billable hours and an increase in billing rates. Excluding the
impact of foreign exchange, revenues for this segment increased 7.3% during the
third quarter of 2022. During the third quarter of 2022, billable hours for this
segment increased by 1% to 74,000 as compared to 73,000 during the same period
last year. Utilization in this segment decreased to 66% during

                                     - 21 -
--------------------------------------------------------------------------------

the third quarter of 2022 as compared to 68% during the same period last year.
The increase in revenues was due to expansion of our health data science work.
The decrease in utilization was due to investments in recruiting and marketing
in our Health Practice. Technical full-time equivalent employees in this segment
increased 4% to 216 during the third quarter of 2022 as compared to 208 during
the same period last year due to our recruiting and retention efforts.

Compensation and Related Expenses



                                            Three Months Ended
                                      September 30,       October 1,       

Percent


(in thousands, except percentages)        2022               2021          

Change

Compensation and related expenses $ 62,779 $ 64,138

   -2.1 %
Percentage of total revenues                    49.4 %           55.1 %



The decrease in compensation and related expenses during the third quarter of
2022 was due to a change in the value of assets associated with our deferred
compensation plan, partially offset by an increase in payroll expense and an
increase in fringe benefits. During the third quarter of 2022, deferred
compensation expense decreased by $4,667,000 with a corresponding decrease to
other income, net, as compared to the same period last year, due to the change
in value of assets associated with our deferred compensation plan. This decrease
consisted of a decrease in the value of plan assets of $4,925,000 during the
third quarter of 2022 as compared to a decrease in the value of plan assets of
$258,000 during the same period last year. Payroll expense increased by
$2,690,000 and fringe benefits increased by $307,000 during the third quarter of
2022 due to the impact of our annual salary adjustments and an increase in
technical full-time equivalent employees. We expect our compensation expense,
excluding the change in value of deferred compensation plan assets, to increase
as we selectively add new talent and adjust compensation to market conditions.

Other Operating Expenses

                                            Three Months Ended
                                      September 30,        October 1,       Percent
(in thousands, except percentages)        2022                2021          Change
Other operating expenses             $         8,822      $      8,017          10.0 %
Percentage of total revenues                     6.9 %             6.9 %



Other operating expenses include facilities-related costs, technical materials,
computer-related expenses and depreciation and amortization of property,
equipment and leasehold improvements. The increase in other operating expenses
during the third quarter of 2022 was primarily due to an increase in occupancy
expense of $400,000, an increase in information technology related expenses of
$253,000, and an increase in office expenses of $132,000. The increases in
occupancy expenses and office expenses were due to growth in technical full-time
equivalent employees and the transition back to our offices from a fully remote
work environment. The increases in information technology related expenses were
due to continued investment in our corporate infrastructure. We expect other
operating expenses to grow as we selectively add new talent, make investments in
our corporate infrastructure, and transition our workforce back to our offices
as COVID-19 pandemic related business restrictions are lifted.

Reimbursable Expenses

                                            Three Months Ended
                                      September 30,       October 1,       Percent
(in thousands, except percentages)        2022               2021          Change
Reimbursable expenses                $        12,036     $      7,938          51.6 %
Percentage of total revenues                     9.5 %            6.8 %




                                     - 22 -

--------------------------------------------------------------------------------


The amount of reimbursable expenses will vary from quarter to quarter depending
on the nature of our projects. The increase in reimbursable expenses during the
third quarter of 2022 was primarily due to an increase in project-related travel
and other project-related expenses as COVID-19 pandemic-related business and
travel restrictions eased.

General and Administrative Expenses



                                             Three Months Ended
                                       September 30,        October 1,      

Percent


(in thousands, except percentages)         2022                2021         

Change

General and administrative expenses $ 6,729 $ 4,193

     60.5 %
Percentage of total revenues                      5.3 %             3.6 %



The increase in general and administrative expenses was primarily due to an
increase in travel and meals of $1,710,000, an increase in outside consulting
expense of $485,000, an increase in recruiting expenses of 167,000, and several
other individually insignificant increases. The increase in travel and meals was
due to a firm-wide managers' meeting held during the third quarter of 2022 and
the continued easing of COVID-19 pandemic-related business and travel
restrictions. The increase in outside consulting expense was due to several
ongoing projects associated with investments in our corporate infrastructure.
The increases in recruiting expenses was due to the increase in technical
full-time equivalent employees. We expect general and administrative expenses to
increase as we selectively add new talent, expand our business development and
staff development initiatives, and increase travel and meal expenses as COVID-19
pandemic related business restrictions phase out.

Operating Income


                                            Three Months Ended
                                      September 30,       October 1,      

Percent


(in thousands, except percentages)        2022               2021          

Change

Engineering and Other Scientific $ 39,385 $ 36,676

    7.4 %
Environmental and Health                       6,378            5,851          9.0 %
Total segment operating income                45,763           42,527          7.6 %
Corporate operating expense                   (8,950 )        (10,408 )      -14.0 %
Total operating income               $        36,813     $     32,119         14.6 %


The increase in operating income for our Engineering and Other Scientific
segment during the third quarter of 2022 as compared to the same period last
year was due to an increase in revenues partially offset by an increase in
expenses. The increase in revenues was driven by demand for our services across
the consumer products, utilities, and automotive sectors. The increase in
operating income for our Environmental and Health segment was due to an increase
in revenues. The increase in revenues was driven by expansion of our health data
science work.

                                     - 23 -
--------------------------------------------------------------------------------


Certain operating expenses are excluded from the Company's measure of segment
operating income. These expenses include the costs associated with our human
resources, finance, information technology, and business development groups; the
deferred compensation expense/benefit due to the change in value of assets
associated with our deferred compensation plan; stock-based compensation
associated with restricted stock unit and stock option awards; and the change in
our allowance for contract losses and doubtful accounts.

The decrease in corporate operating expenses during the third quarter of 2022 as
compared to the same period last year was primarily due to a decrease in
deferred compensation expense partially offset by an increase in the costs
associated with our human resources, finance, information technology and
business development groups. During the third quarter of 2022, deferred
compensation expense decreased $4,667,000, with a corresponding decrease to
other income, net, as compared to the same period last year, due to the change
in value of assets associated with our deferred compensation plan. This decrease
consisted of a decrease in the value of plan assets of $4,925,000 during the
third quarter of 2022 as compared to a decrease in the value of plan assets of
$258,000 during the same period last year.

Other Income, Net

                                            Three Months Ended
                                      September 30,        October 1,       Percent
(in thousands, except percentages)        2022                2021          Change
Other income, net                    $        (3,337 )    $        270       -1335.9 %
Percentage of total revenues                    -2.6 %             0.2 %



Other income, net, consists primarily of changes in the value of assets
associated with our deferred compensation plan, interest income earned on
available cash, cash equivalents and short-term investments, and rental income
from leasing space in our Silicon Valley and Natick facilities. The decrease in
other income, net, was primarily due to a change in the value of assets
associated with our deferred compensation plan partially offset by an increase
in the gain on foreign exchange, and an increase in interest income. During the
third quarter of 2022, other income, net, decreased by $4,667,000 with a
corresponding decrease to deferred compensation expense, as compared to the same
period last year, due to a change in the value of assets associated with our
deferred compensation plan. This decrease consisted of a decrease in the value
of the plan assets of $4,925,000 during the third quarter of 2022 as compared to
a decrease in the value of the plan assets of $258,000 during the same period
last year. The increase in the gain on foreign exchange of $325,000 was due to
an increase in the value of assets denominated in currencies that are not our
functional currency. The increase in interest income of $625,000 was due to an
increase in interest rates.

Income Taxes

                                            Three Months Ended
                                      September 30,        October 1,       Percent
(in thousands, except percentages)        2022                2021          Change
Income taxes                         $         9,034      $      7,815          15.6 %
Percentage of total revenues                     7.1 %             6.7 %
Effective tax rate                              27.0 %            24.1 %



The increase in income tax expense was due to a decrease in the excess tax
benefit associated with stock-based awards. There was no excess tax benefit
associated with stock-based awards during the third quarter of 2022. The excess
tax benefit associated with stock-based awards was $1,066,000 during the third
quarter of 2021. Excluding the impact of the excess tax benefit, the effective
tax rate would have been 27.4% during the third quarter of 2021.


Nine Months Ended September 30, 2022 compared to Nine Months Ended October 1, 2021



Revenues


                                     - 24 -
--------------------------------------------------------------------------------

                                            Nine Months Ended
                                      September 30,       October 1,       

Percent


(in thousands, except percentages)        2022               2021          

Change

Engineering and Other Scientific $ 321,168 $ 288,848

   11.2 %
Percentage of total revenues                    83.2 %           81.9 %
Environmental and Health                      64,770           63,915           1.3 %
Percentage of total revenues                    16.8 %           18.1 %
Total revenues                       $       385,938     $    352,763           9.4 %



The increase in revenues for our Engineering and Other Scientific segment was
due to an increase in billable hours and an increase in billing rates. During
the first nine months of 2022, billable hours for this segment increased by 4%
to 874,000 as compared to 838,000 during the same period last year. Utilization
for this segment decreased to 77% during the first nine months of 2022 as
compared to 79% during the same period last year. Growth was driven by demand
for Exponent's services across a broad range of industries and use cases. In
addition to the steady increase in litigation support and human participant
studies, our multidisciplinary battery team continued to see demand for its
solutions in electric vehicles and energy storage. Our work in international
arbitrations and integrity management advisory services continued at strong
levels. Technical full-time equivalent employees in this segment increased 6% to
725 during the first nine months of 2022 as compared to 682 for the same period
last year due to our recruiting and retention efforts.

The increase in revenues for our Environmental and Health segment was due to an
increase in billable hours and an increase in our realized billing rate.
Excluding the impact of foreign exchange, revenues for this segment increased
4.3% during the first nine months of 2022. During the first nine months of 2022,
billable hours for this segment increased by 2% to 236,000 as compared to
232,000 during the same period last year. Utilization in this segment decreased
to 69% during the first nine months of 2022 as compared to 70% during the same
period last year. This segment benefited from increased activity in
litigation-related projects and support of human participant studies. Technical
full-time equivalent employees in this segment increased by 4% to 219 during the
first nine months of 2022 as compared to 211 during the same period last year
due to our recruiting and retention efforts.

Compensation and Related Expenses



                                            Nine Months Ended
                                      September 30,       October 1,       

Percent


(in thousands, except percentages)        2022               2021          

Change

Compensation and related expenses $ 189,982 $ 210,491

   -9.7 %
Percentage of total revenues                    49.2 %           59.7 %



The decrease in compensation and related expenses during the first nine months
of 2022 was due to a change in the value of assets associated with our deferred
compensation plan partially offset by an increase in payroll expense, an
increase in fringe benefits, and an increase in bonus expense. During the first
nine months of 2022, deferred compensation expense decreased $30,881,000 with a
corresponding decrease to other income, net, as compared to the same period last
year, due to the change in value of assets associated with our deferred
compensation plan. This decrease consisted of a decrease in the value of plan
assets of $20,884,000 during the first nine months of 2022 as compared to an
increase in the value of plan assets of $9,997,000 during the same period last
year. Payroll expense increased $7,157,000 during the first nine months of 2022
due to the increase in technical full-time equivalent employees and the impact
of our annual salary adjustments. Fringe benefits increased by $1,366,000 during
the first nine months of 2022 due to the increase in technical full-time
equivalent employees and the impact of our annual salary adjustments. Bonus
expense increased by $1,210,000 during the first nine months of 2022 due to a
corresponding increase to our bonus pool which is equal to 33% of income before
income taxes, interest income, bonus expense, and stock-based compensation. We
expect our compensation expense, excluding the change in value of deferred
compensation plan assets, to increase as we selectively add new talent and
adjust compensation to market conditions.

Other Operating Expenses


                                     - 25 -
--------------------------------------------------------------------------------

                                            Nine Months Ended
                                      September 30,       October 1,       

Percent


(in thousands, except percentages)        2022               2021          Change
Other operating expenses             $        25,742     $     23,848           7.9 %
Percentage of total revenues                     6.7 %            6.8 %



Other operating expenses include facilities-related costs, technical materials,
computer-related expenses and depreciation and amortization of property,
equipment and leasehold improvements. The increase in other operating expenses
during the first nine months of 2022 was primarily due to an increase in
occupancy expense of $763,000, an increase in information technology related
expenses of $578,000 and an increase in depreciation expense of $281,000. The
increase in occupancy expenses was due to growth in technical full-time
equivalent employees and the transition back to our offices from a fully remote
work environment. The increases in information technology related expenses and
depreciation expense were due to continued investment in our corporate
infrastructure. We expect other operating expenses to grow as we selectively add
new talent, make investments in our corporate infrastructure, and transition our
workforce back to our offices as COVID-19 pandemic-related business restrictions
are lifted.

Reimbursable Expenses

                                            Nine Months Ended
                                      September 30,       October 1,       Percent
(in thousands, except percentages)        2022               2021          Change
Reimbursable expenses                $        34,707     $     22,249          56.0 %
Percentage of total revenues                     9.0 %            6.3 %



The amount of reimbursable expenses will vary from quarter to quarter depending
on the nature of our projects. The increase in reimbursable expenses during the
first nine months of 2022 was primarily due to an increase in project-related
travel and other project-related expenses as COVID-19 business and travel
restrictions eased.

General and Administrative Expenses



                                             Nine Months Ended
                                       September 30,       October 1,       

Percent


(in thousands, except percentages)         2022               2021          

Change

General and administrative expenses $ 16,700 $ 10,626

    57.2 %
Percentage of total revenues                      4.3 %            3.0 %



The increase in general and administrative expenses was primarily due to an
increase in travel and meals of $3,303,000, an increase in outside consulting
expense of $1,050,000, an increase in recruiting expenses of $562,000, an
increase in marketing and business development expenses of $268,000 and several
other individually insignificant increases. The increase in travel and meals was
due to a firm-wide managers' meeting held during the third quarter of 2022 and
the continued easing of COVID-19 pandemic-related business and travel
restrictions. The increase in outside consulting expense was due to several
ongoing projects associated with investments in our corporate infrastructure.
The increase in recruiting expense was due to the increase in technical
full-time equivalent employees. The increase in marketing and business
development expenses was due to an increase in our business development
activities. We expect general and administrative expenses to increase as we
selectively add new talent, expand our business development and staff
development initiatives, and increase travel and meal expenses as COVID-19
pandemic related business restrictions phase out.

Operating Income


                                     - 26 -
--------------------------------------------------------------------------------

                                            Nine Months Ended
                                      September 30,       October 1,      

Percent


(in thousands, except percentages)        2022               2021          

Change

Engineering and Other Scientific $ 117,907 $ 108,646

    8.5 %
Environmental and Health                      21,059           21,265         -1.0 %
Total segment operating income               138,966          129,911          7.0 %
Corporate operating expense                  (20,159 )        (44,362 )      -54.6 %
Total operating income               $       118,807     $     85,549         38.9 %



The increase in operating income for our Engineering and Other Scientific
segment during the first nine months of 2022 as compared to the same period last
year was due to an increase in revenues partially offset by an increase in
expenses. The increase in revenues was due to an increase in billable hours and
an increase in billing rates. Growth was driven by strong demand for Exponent's
services across a broad range of industries and use cases. In addition to the
steady increase in litigation support and human participant studies, our
multidisciplinary battery team continued to see demand for its solutions in
electric vehicles and energy storage. Our work in international arbitrations and
integrity management advisory services continued at strong levels. The decrease
in operating income for our Environmental and Health segment was due to
investments in recruiting and marketing in our Health Practice.

Certain operating expenses are excluded from our measure of segment operating
income. These expenses include the costs associated with our human resources,
finance, information technology, and business development groups; the deferred
compensation expense/benefit due to the change in value of assets associated
with our deferred compensation plan; stock-based compensation associated with
restricted stock unit and stock option awards; and the change in our allowance
for contract losses and doubtful accounts.

The decrease in corporate operating expenses during the first nine months of
2022 as compared to the same period last year was primarily due to a decrease in
deferred compensation expense partially offset by an increase in the costs
associated with our human resources, finance, information technology and
business development groups. During the first nine months of 2022, deferred
compensation expense decreased $30,881,000, with a corresponding decrease to
other income, net, as compared to the same period last year, due to the change
in value of assets associated with our deferred compensation plan. This decrease
consisted of a decrease in the value of plan assets of $20,884,000 during the
first nine months of 2022 as compared to an increase in the value of plan assets
of $9,997,000 during the same period last year.

Other Income, Net


                                            Nine Months Ended
                                      September 30,       October 1,      

Percent


(in thousands, except percentages)        2022               2021          Change
Other income, net                    $       (17,092 )   $     11,633       -246.9 %
Percentage of total revenues                    -4.4 %            3.3 %



Other income, net, consists primarily of changes in the value of assets
associated with our deferred compensation plan, interest income earned on
available cash, cash equivalents and short-term investments, and rental income
from leasing space in our Silicon Valley and Natick facilities. The decrease in
other income, net, was primarily due to a change in the value of assets
associated with our deferred compensation plan partially offset by an increase
in the realized gain on foreign exchange and an increase in interest income.
During the first nine months of 2022, other income, net, decreased $30,881,000
with a corresponding decrease to deferred compensation expense, as compared to
the same period last year, due to a change in the value of assets associated
with our deferred compensation plan. This decrease consisted of a decrease in
the value of the plan assets of $20,884,000 during the first nine months of 2022
as compared to an increase in the value of the plan assets of $9,997,000 during
the same period last year. During the first nine months of 2022, other income,
net, increased by $1,218,000 as compared to the same period last year due to a
change in the realized gain/loss on foreign exchange. This increase consisted of
a realized gain on foreign exchange of $776,000 during the first nine months of
2022 as compared to a realized loss on foreign exchange of $442,000 during the
same period last year. During the first nine months of 2022, interest income
increased by $780,000 as compared to the same period last year due to an
increase in interest rates.

Income Taxes

                                     - 27 -

--------------------------------------------------------------------------------


                                            Nine Months Ended
                                      September 30,       October 1,       

Percent


(in thousands, except percentages)        2022               2021          Change
Income taxes                         $        21,909     $     16,360          33.9 %
Percentage of total revenues                     5.7 %            4.6 %
Effective tax rate                              21.5 %           16.8 %



The excess tax benefit associated with stock-based awards was $6,040,000 during
the first nine months of 2022 as compared to $9,889,000 during the same period
last year. Excluding the impact of the excess tax benefit, the effective tax
rate would have been 27.5% during the first nine months of 2022 as compared to
27.0% during the same period last year. The increase in our effective tax rate,
excluding the impact of the excess tax benefit, was due primarily to an increase
in non-deductible officer compensation.

                                     - 28 -
--------------------------------------------------------------------------------

LIQUIDITY AND CAPITAL RESOURCES



We believe our existing balances of cash, cash equivalents, and cash generated
from operations will be sufficient to satisfy our working capital needs, capital
expenditures, outstanding commitments, stock repurchases, dividends and other
liquidity requirements over at least the next twelve months.

                                                                Nine Months Ended
                                                         September 30,       October 1,
(in thousands)                                               2022               2021
Net cash provided by operating activities               $        53,237     $      70,378
Net cash (used in) / provided by investing activities            (9,108 )   

14,569


Net cash used in financing activities                          (190,556 )   

(52,766 )





We financed our business during the first nine months of 2022 through available
cash. As of September 30, 2022, our cash and cash equivalents were $148,443,000
as compared to $297,687,000 at December 31, 2021.

Generally, our net cash provided by operating activities is used to fund our day
to day operating activities. First quarter operating cash requirements are
generally higher due to payment in the first quarter of our annual bonuses
accrued during the prior year. Our largest source of operating cash flows is
collections from our clients. Our primary uses of cash from operating activities
are for employee related expenditures, leased facilities, taxes, and general
operating expenses including marketing and travel.

The increase in net cash used in investing activities during the first nine months of 2022, as compared to the net cash provided by investing activities during the same period last year, was due to a decrease in the maturity of short-term investments partially offset by a decrease in the purchase of short-term investments and an increase in capital expenditures due to an increase in investment in our corporate infrastructure.



The increase in net cash used in financing activities during the first nine
months of 2022, as compared to the same period last year, was due to an increase
in repurchases of our common stock and an increase in dividends partially offset
by a reduction in payroll taxes for restricted stock units.

We expect to continue our investing activities, including capital expenditures.
Furthermore, cash reserves may be used to repurchase shares of common stock
under our stock repurchase programs, pay dividends, or strategically acquire
professional service firms that are complementary to our business.

We maintain a nonqualified deferred compensation plan for the benefit of a
select group of highly compensated employees. Vested amounts due under the plan
of $85,453,000 were recorded as a long-term liability on our unaudited condensed
consolidated balance sheet at September 30, 2022. Vested amounts due under the
plan of $9,049,000 were recorded as a current liability on our unaudited
condensed consolidated balance sheet at September 30, 2022. Our assets that are
earmarked to pay benefits under the plan are held in a rabbi trust and are
subject to the claims of our creditors. As of September 30, 2022, invested
amounts under the plan of $83,722,000 were recorded as a long-term asset on our
unaudited condensed consolidated balance sheet. As of September 30, 2022,
invested amounts under the plan of $10,857,000 were recorded as a current asset
on our unaudited condensed consolidated balance sheet.

As permitted under Delaware law, we have agreements whereby we indemnify our
officers and directors for certain events or occurrences while the officer or
director is, or was, serving at our request in such capacity. The
indemnification period covers all pertinent events and occurrences during the
officer's or director's lifetime. The maximum potential amount of future
payments we could be required to make under these indemnification agreements is
unlimited; however, we have director and officer insurance coverage that reduces
our exposure and enables us to recover a portion of any future amounts paid.

                                     - 29 -
--------------------------------------------------------------------------------

Non-GAAP Financial Measures



Regulation G, Conditions for Use of Non-Generally Accepted Accounting Principles
("Non-GAAP") Financial Measures, and other U.S. Securities and Exchange
Commission ("SEC") rules and regulations define and prescribe the conditions for
use of Non-GAAP financial information. Generally, a Non-GAAP financial measure
is a numerical measure of a company's performance, financial position or cash
flow that either excludes or includes amounts that are not normally excluded or
included in the most directly comparable measure calculated and presented in
accordance with GAAP. We closely monitor two financial measures, EBITDA and
EBITDAS, which meet the definition of Non-GAAP financial measures. We define
EBITDA as net income before income taxes, net interest income, depreciation and
amortization. We define EBITDAS as EBITDA before stock-based compensation. The
Company regards EBITDA and EBITDAS as useful measures of operating performance
to complement operating income, net income and other GAAP financial performance
measures. Additionally, management believes that EBITDA and EBITDAS provide
meaningful comparisons of past, present and future operating results. These
measures are used to evaluate our financial results, develop budgets and
determine employee compensation. These measures, however, should be considered
in addition to, and not as a substitute for or superior to, operating income,
cash flows, or other measures of financial performance prepared in accordance
with GAAP. A reconciliation of the Non-GAAP measures to the nearest comparable
GAAP measure is set forth below.

The following table shows EBITDA (determined as shown in the reconciliation table below) as a percentage of revenues before reimbursements for the three months ended September 30, 2022 and October 1, 2021:



                                            Three Months Ended              

Nine Months Ended


                                      September 30,       October 1,       September 30,       October 1,
(in thousands, except percentages)        2022               2021              2022               2021

Revenues before reimbursements $ 115,143 $ 108,467 $

       351,231     $    330,514
EBITDA                               $        34,561     $     34,021     $       106,105     $    102,071
EBITDA as a % of revenues before
  reimbursements                                30.0 %           31.4 %              30.2 %           30.9 %




                                     - 30 -

--------------------------------------------------------------------------------

The decrease in EBITDA as a percentage of revenues before reimbursements during
the third quarter of 2022 as compared to the same period last year was primarily
due to the decrease in utilization and an increase in other operating and
general and administrative expenses. Our utilization decreased to 73% during the
third quarter of 2022 as compared to 76% during the same period last year.
Utilization during the third quarter of 2021 was historically strong. Other
operating and general and administrative expenses increased during the third
quarter of 2022 due to an increase in travel and meals associated with a
firm-wide managers' meeting held during the third quarter of 2022 and the
continued easing of COVID-19 pandemic-related business and travel restrictions,
an increase in technical full-time equivalent employees, investments in our
corporate infrastructure, and an increase in marketing and business development
activities.

The decrease in EBITDA as a percentage of revenues before reimbursements during
the first nine months of 2022 as compared to the same period last year was
primarily due to a decrease in utilization and an increase in other operating
and general and administrative expenses. Other operating and general and
administrative expenses increased during the first nine months of 2022 due to an
increase in travel and meals associated with a firm-wide managers' meeting held
during the third quarter of 2022 and the continued easing of COVID-19
pandemic-related business and travel restrictions, an increase in technical
full-time equivalent employees, investments in our corporate infrastructure, and
an increase in marketing and business development activities.

The following table is a reconciliation of EBITDA and EBITDAS to the most comparable GAAP measure, net income, for the three and nine months ended September 30, 2022 and October 1, 2021:



                                        Three Months Ended                  

Nine Months Ended


                                  September 30,       October 1,       September 30,       October 1,
(in thousands)                        2022               2021              2022               2021
Net income                       $        24,442     $     24,574     $        79,806     $     80,822
Add back (subtract):
Income taxes                               9,034            7,815              21,909           16,360
Interest income, net                        (638 )            (13 )              (834 )            (54 )
Depreciation and amortization              1,723            1,645               5,224            4,943
EBITDA                                    34,561           34,021             106,105          102,071
Stock-based compensation                   4,605            4,365              16,072           15,239
EBITDAS                          $        39,166     $     38,386     $       122,177     $    117,310




                                     - 31 -

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses